{"podcast":{"title":"Brisbane News Today | 2 Min News | The Daily News Now!","slug":"brisbane-news-today-2-min-news-the-daily-news-now-7581033","podcast_index_feed_id":7581033,"rss_url":"https://feeds.fastcast.ai/phoenix-mercury-the-daily-news-now.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/cover/fcd411e3-040e-402a-bd74-0f5d66e42553.png","author":"The Daily News Now!","episode_count":822,"summary":"Hosted by Corey with the Story, Brisbane News Today delivers fast, focused daily updates on the stories shaping Brisbane—from local news and business to culture, sports, and community developments. Designed for quick, on-the-go listening, each episode brings you up to speed in minutes. Produced by AI for speed, consistency, and global scale, the show is part of The Daily News Now network—bringing local news to every city in the world and keeping communities connected. Brisbane News Today is your daily snapshot of what’s happening across the city. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-09-16T06:19:41.125965+00:00","page_url":"https://stenobird.com/podcast/brisbane-news-today-2-min-news-the-daily-news-now-7581033"},"episode":{"title":"MS Drugs Stay on PBS Amid Price Pressure | Brisbane News","slug":"ms-drugs-stay-on-pbs-amid-price-pressure-brisbane-news","published_at":"2026-07-16T12:14:46+00:00","page_url":"https://stenobird.com/podcast/brisbane-news-today-2-min-news-the-daily-news-now-7581033/ms-drugs-stay-on-pbs-amid-price-pressure-brisbane-news","show_page_url":"https://stenobird.com/podcast/brisbane-news-today-2-min-news-the-daily-news-now-7581033","url":"https://sources.thednn.ai/f9df1f8fcc8f66f5","audio_url":"https://api.fastcast.ai/audio/fe1cead1-4d96-4a99-8b23-4f4d7714e26c.mp3","summary":"The government has decided to keep key MS drugs on the PBS, ensuring patients continue to access them at low cost despite pressure from drugmakers threatening to pull them — a move that highlights the ongoing tug-of-war between affordability and innovation in Australia’s healthcare system. With a new cheaper MS drug on the market, manufacturers are being forced to accept lower prices, sparking backlash from companies claiming it undermines their R&D. Advocacy groups counter that these firms are among the world’s most profitable and that US pricing pressures shouldn’t dictate Australian costs. The PBAC is set to review usage by year’s end, as the government seeks to balance patient access with fiscal responsibility in a system where subsidies make life-saving treatments affordable — but not without tension. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/f9df1f8fcc8f66f5","meta_description":"The government has decided to keep key MS drugs on the PBS, ensuring patients continue to access them at low cost despite pressure from drugmakers threate…","key_points":[],"chapters":[],"topics":[],"duration_seconds":142,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/brisbane-news-today-2-min-news-the-daily-news-now-7581033/episodes/ms-drugs-stay-on-pbs-amid-price-pressure-brisbane-news/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/brisbane-news-today-2-min-news-the-daily-news-now-7581033/ms-drugs-stay-on-pbs-amid-price-pressure-brisbane-news.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}